Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04514926 · ClinicalTrials.gov registry record
Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 62
- Enrollment target
NCT04514926: Completed study, sponsored by University of California, San Francisco.
NCT04514926 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04514926 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This is an observational, clinic-based, single center study of 120 subjects. Participants will be comprised of patients seen in the outpatient faculty practice in ambulatory care at the UCSF Parnassus campus. Study investigators will enroll 20 healthy participants with no history of lung disease, 50 asthmatics who are newly prescribed therapeutic proteins for their asthma, and 50 asthmatics already being treated with therapeutic proteins for their asthma. Participants will be seen at 1 to 3 visits and provide blood samples at each visit.
Primary Outcome
The investigators will compare lymphocyte counts in healthy controls to asthmatics on and off therapeutic proteins.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2023-05-26 |
What the finished NCT04514926 record still lists
NCT04514926 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04514926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04514926 about?
NCT04514926 is a clinical study titled "Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins". This is an observational, clinic-based, single center study of 120 subjects. Participants will be comprised of patients seen in the outpatient faculty practice in ambulatory care at the UCSF Parnassus campus. Study investigators will enroll 20 healthy participants with no history of lung disease, 50...
What is the current status of trial NCT04514926?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2020-11-01. Estimated completion is 2023-05-26.
Who is sponsoring clinical trial NCT04514926?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI